首页> 外文会议>NSTI Nanotechnology Conference and Trade Show >Peptidic nanoparticles for cancer therapy and diagnosis
【24h】

Peptidic nanoparticles for cancer therapy and diagnosis

机译:肽纳米粒子用于癌症治疗和诊断

获取原文

摘要

A challenging topic in cancer research is to create drug system that can deliver in a specific and non-cytotoxic manner a therapeutic compound. Usually, tumor targeting requires very specific compounds. Currently, peptide analogues like somatostatin, neurotensin, or bombesin are used to target G-coupled receptors, which are over-expressed on tumor cells. We have recently designed a novel type of nanoparticles with regular icosahedral symmetry and a diameter of about 16 nm, which self-assemble from single polypeptide chains. Here we propose an innovative drug targeting and delivery system based on such nanoparticles functionalized with somatostatin or bombesin as targeting units. Moreover, these nanoparticles can be radiolabeled with Technetium-99m or other radionuclides for diagnosis and treatment of cancer.
机译:癌症研究中有挑战性的话题是制造可以以特定和非细胞毒性方式提供治疗化合物的药物系统。通常,肿瘤靶向需要非常特异性的化合物。目前,肽类似物如生长抑制菌素,神经调度素或Bombesin用于靶向靶向肿瘤细胞上的G偶联受体。我们最近设计了一种具有常规ICOSAHEDRAL对称性的新型纳米颗粒和直径约16nm,其自组装由单个多肽链。在这里,我们提出了一种基于用生长抑素或Bombesin官能化的纳米颗粒作为靶向单位的纳米颗粒的创新药物靶向和递送系统。此外,这些纳米颗粒可以用TechNetium-99M或其他放射性核素放射性标记,用于诊断和治疗癌症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号